State of Alaska Department of Revenue Has $9.88 Million Stake in Elevance Health, Inc. $ELV

Key Points

• State of Alaska Department of Revenue trimmed its stake in Elevance Health by 23.7% in Q4, selling 8,776 shares to hold 28,188 shares worth $9.88 million.
• Elevance beat EPS expectations with $3.33 per share (vs. $3.10) and reported revenue of $49.31 billion, up 9.6% year‑over‑year, though revenue slightly missed estimates.
• Institutional investors own about 89.24% of the stock; analysts' consensus is a "Hold" with a target of $384.67 versus a recent share price near $316, and the company raised its quarterly dividend to $1.72 (≈2.2% yield).

State of Alaska Department of Revenue trimmed its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 23.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,188 shares of the company's stock after selling 8,776 shares during the period. State of Alaska Department of Revenue's holdings in Elevance Health were worth $9,880,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in ELV. Physician Wealth Advisors Inc. raised its position in shares of Elevance Health by 331.6% in the third quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company's stock valued at $26,000 after buying an additional 63 shares in the last quarter. Activest Wealth Management raised its position in shares of Elevance Health by 66.7% in the third quarter. Activest Wealth Management now owns 85 shares of the company's stock valued at $27,000 after buying an additional 34 shares in the last quarter. Rossby Financial LCC raised its position in shares of Elevance Health by 110.0% in the third quarter. Rossby Financial LCC now owns 84 shares of the company's stock valued at $28,000 after buying an additional 44 shares in the last quarter. Motco raised its position in shares of Elevance Health by 334.8% in the third quarter. Motco now owns 100 shares of the company's stock valued at $32,000 after buying an additional 77 shares in the last quarter. Finally, True Wealth Design LLC raised its position in shares of Elevance Health by 431.8% in the third quarter. True Wealth Design LLC now owns 117 shares of the company's stock valued at $38,000 after buying an additional 95 shares in the last quarter. 89.24% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ELV has been the subject of a number of analyst reports. Jefferies Financial Group lowered their price objective on shares of Elevance Health from $401.00 to $395.00 and set a "buy" rating for the company in a research report on Friday, January 30th. Wolfe Research set a $425.00 price objective on shares of Elevance Health and gave the company an "outperform" rating in a research report on Thursday, January 8th. Mizuho lowered their price objective on shares of Elevance Health from $413.00 to $350.00 and set an "outperform" rating for the company in a research report on Wednesday, March 11th. UBS Group set a $400.00 price objective on shares of Elevance Health in a research report on Thursday, January 29th. Finally, Wells Fargo & Company lowered their price objective on shares of Elevance Health from $424.00 to $391.00 and set an "overweight" rating for the company in a research report on Friday, January 30th. Twelve analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $384.67.

Elevance Health Stock Performance

Shares of Elevance Health stock opened at $316.07 on Tuesday. The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.70. The stock has a market cap of $69.43 billion, a price-to-earnings ratio of 12.58, a P/E/G ratio of 1.71 and a beta of 0.49. The company's fifty day moving average is $310.73 and its 200 day moving average is $332.12. Elevance Health, Inc. has a twelve month low of $273.71 and a twelve month high of $443.29.

Elevance Health (NYSE:ELV - Get Free Report) last issued its quarterly earnings results on Wednesday, January 28th. The company reported $3.33 EPS for the quarter, beating analysts' consensus estimates of $3.10 by $0.23. The business had revenue of $49.31 billion for the quarter, compared to analysts' expectations of $49.52 billion. Elevance Health had a net margin of 2.84% and a return on equity of 15.59%. The business's quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.84 earnings per share. Elevance Health has set its FY 2026 guidance at 25.500- EPS. Sell-side analysts forecast that Elevance Health, Inc. will post 33.96 EPS for the current year.

Elevance Health Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 25th. Stockholders of record on Tuesday, March 10th were given a dividend of $1.72 per share. This is a boost from Elevance Health's previous quarterly dividend of $1.71. The ex-dividend date of this dividend was Tuesday, March 10th. This represents a $6.88 dividend on an annualized basis and a dividend yield of 2.2%. Elevance Health's payout ratio is currently 27.39%.

About Elevance Health

Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.

Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.